Walleye Capital LLC Acadia Pharmaceuticals Inc Put Options Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $283,628 - $357,348	19,400 New	19,400 $315,000
Q4 2023 Feb 14, 2024	SELL	$20.78 - $31.77 $12,468 - $19,062	-600 Reduced 6.59%	8,500 $266,000
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $181,308 - $291,189	8,700 Added 2175.0%	9,100 $189,000
Q1 2023 May 15, 2023	SELL	$16.32 - $20.92 $68,544 - $87,864	-4,200 Reduced 91.3%	400 $7,000
Q4 2022 Feb 14, 2023	SELL	$14.2 - $18.63 $5,680 - $7,452	-400 Reduced 8.0%	4,600 $73,000
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $70,550 - $91,350	5,000 New	5,000 $82,000
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $15,554 - $30,807	700 New	700 $25,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.